These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 7884117

  • 1. A randomized comparison of intravenous amrinone versus dobutamine in older patients with decompensated congestive heart failure.
    Rich MW, Woods WL, Davila-Roman VG, Morello PJ, Kurz H, Barbarash R, Spinner L, Sperry J, Beckham V, Coulter L.
    J Am Geriatr Soc; 1995 Mar; 43(3):271-4. PubMed ID: 7884117
    [Abstract] [Full Text] [Related]

  • 2. Comparison of intravenous amrinone and dobutamine in congestive heart failure due to idiopathic dilated cardiomyopathy.
    Marcus RH, Raw K, Patel J, Mitha A, Sareli P.
    Am J Cardiol; 1990 Nov 01; 66(15):1107-12. PubMed ID: 2220638
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the effects of amrinone and dobutamine on hemodynamics and myocardial oxygen balance in dogs with experimental left ventricular failure.
    Fujigaki T, Nakamura H, Fukui S, Miyako M, Haseba S, Gotoh Y.
    J Cardiothorac Anesth; 1989 Aug 01; 3(4):433-40. PubMed ID: 2520916
    [Abstract] [Full Text] [Related]

  • 4. Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure.
    Klein NA, Siskind SJ, Frishman WH, Sonnenblick EH, LeJemtel TH.
    Am J Cardiol; 1981 Jul 01; 48(1):170-5. PubMed ID: 7246440
    [Abstract] [Full Text] [Related]

  • 5. Amrinone versus dobutamine in cardiac surgical patients with severe pulmonary hypertension after cardiopulmonary bypass: a prospective, randomized double-blinded trial.
    Jenkins IR, Dolman J, O'Connor JP, Ansley DM.
    Anaesth Intensive Care; 1997 Jun 01; 25(3):245-9. PubMed ID: 9209604
    [Abstract] [Full Text] [Related]

  • 6. Amrinone and dobutamine as primary treatment of low cardiac output syndrome following coronary artery surgery: a comparison of their effects on hemodynamics and outcome.
    Dupuis JY, Bondy R, Cattran C, Nathan HJ, Wynands JE.
    J Cardiothorac Vasc Anesth; 1992 Oct 01; 6(5):542-53. PubMed ID: 1421065
    [Abstract] [Full Text] [Related]

  • 7. Calcium inhibits the cardiac stimulating properties of dobutamine but not of amrinone.
    Butterworth JF, Zaloga GP, Prielipp RC, Tucker WY, Royster RL.
    Chest; 1992 Jan 01; 101(1):174-80. PubMed ID: 1729065
    [Abstract] [Full Text] [Related]

  • 8. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
    La Vecchia L, Bottero M, Centofante P, Bedogni F, Ometto R, Cera A, Fortunato A.
    G Ital Cardiol; 1996 Aug 01; 26(8):863-74. PubMed ID: 9005168
    [Abstract] [Full Text] [Related]

  • 9. Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function.
    Capomolla S, Pozzoli M, Opasich C, Febo O, Riccardi G, Salvucci F, Maestri R, Sisti M, Cobelli F, Tavazzi L.
    Am Heart J; 1997 Dec 01; 134(6):1089-98. PubMed ID: 9424070
    [Abstract] [Full Text] [Related]

  • 10. Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug.
    Hermiller JB, Leithe ME, Magorien RD, Unverferth DV, Leier CV.
    J Pharmacol Exp Ther; 1984 Feb 01; 228(2):319-26. PubMed ID: 6694112
    [Abstract] [Full Text] [Related]

  • 11. Comparison of intravenous milrinone and dobutamine for congestive heart failure secondary to either ischemic or dilated cardiomyopathy.
    Biddle TL, Benotti JR, Creager MA, Faxon DP, Firth BG, Fitzpatrick PG, Konstam MA, Krebs C, Walton L, Kershner RP.
    Am J Cardiol; 1987 Jun 01; 59(15):1345-50. PubMed ID: 3591689
    [Abstract] [Full Text] [Related]

  • 12. [Severe cardiac decompensation: value in the early hours of a combination of amrinone and dobutamine].
    Fosse JP, Pourriat JL, Hoang P, Fournier JL, Aïtkaciali F, Cupa M.
    Cah Anesthesiol; 1989 Dec 01; 37(8):581-5. PubMed ID: 2637778
    [Abstract] [Full Text] [Related]

  • 13. Comparative vasoactive therapy for heart failure.
    Benotti JR, McCue JE, Alpert JS.
    Am J Cardiol; 1985 Jul 22; 56(3):19B-24B. PubMed ID: 4025154
    [Abstract] [Full Text] [Related]

  • 14. Comparative haemodynamic dose-response effects of dobutamine and amrinone in left ventricular failure complicating acute myocardial infarction.
    Silke B, Verma SP, Midtbo KA, Reynolds G, Taylor SH.
    J Cardiovasc Pharmacol; 1987 Jan 22; 9(1):19-25. PubMed ID: 2434789
    [Abstract] [Full Text] [Related]

  • 15. Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.
    Mager G, Klocke RK, Kux A, Höpp HW, Hilger HH.
    Am Heart J; 1991 Jun 22; 121(6 Pt 2):1974-83. PubMed ID: 1852090
    [Abstract] [Full Text] [Related]

  • 16. Beneficial hemodynamic effects of prostaglandin E1 infusion in catecholamine-dependent heart failure: results of a prospective, randomized, controlled study.
    Pacher R, Globits S, Wutte M, Rödler S, Heinz G, Kreiner G, Radosztics S, Berger R, Presch I, Weber H.
    Crit Care Med; 1994 Jul 22; 22(7):1084-90. PubMed ID: 8026195
    [Abstract] [Full Text] [Related]

  • 17. Additive effects of dobutamine and amrinone on myocardial contractility and ventricular performance in patients with severe heart failure.
    Gage J, Rutman H, Lucido D, LeJemtel TH.
    Circulation; 1986 Aug 22; 74(2):367-73. PubMed ID: 3731427
    [Abstract] [Full Text] [Related]

  • 18. [The hemodynamic profile of amrinone and enoximone in patients with severe heart failure].
    Saborowski F, Peters P, Schneider M.
    Z Kardiol; 1991 Aug 22; 80 Suppl 4():63-7. PubMed ID: 1833900
    [Abstract] [Full Text] [Related]

  • 19. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
    De Vecchis R, Pucciarelli G, Nocerino L, Cocozza M, Setaro A, Torre G, Imperatore F.
    Minerva Cardioangiol; 1998 May 22; 46(5):163-74. PubMed ID: 9842199
    [Abstract] [Full Text] [Related]

  • 20. [Hemodynamic and clinical effects and treatment tolerance with low-dose iv amrinone in patients with refractory heart failure: a multicenter study. The Group for Research on Amrinone in the Treatment of Refractory Heart Failure].
    Dei Cas L, Metra M, Nodari S, Raddino R, Visioli O.
    Cardiologia; 1991 May 22; 36(5):363-71. PubMed ID: 1756541
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.